Pneumococcal disease and vaccination in the Americas: An agenda for accelerated vaccine introduction

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 19, Issue 5, 2006, Pages 340-348

  Garcia, Salvador ^a,b   Levine, Orin S ^c   Cherian, Thomas ^d   Gabastou, Jean Marc ^a,b   Andrus, Jon ^a,b   Flannery, Brendan ^e   Castañeda, Elizabeth ^f   Brandileone, Maria Cristina ^g   Lagos, Rosanna ^h   Asturias, Edwin ⁱ   Iglesias, Jesús Feris ^j   Tregnaghi, Miguel ^k   Ruvinsky, Raúl ^l   Gentile, Angela ^m   Avilés, Gabriela Echániz ⁿ   Hortal, María ^o   Sinha, Anushua ^p   Kvist, Hans ^c  

^a PAN AMERICAN HEALTH ORGANIZATION   (United States)

^b Representación de la Organización Panamericana de la Salud   (Argentina)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f INSTITUTO NACIONAL DE SALUD   (Colombia)

^g INSTITUTO ADOLFO LUTZ   (Brazil)

^h Centro para Vacunas en Desarrollo Chile   (Chile)

ⁱ Valle University   (Guatemala)

^j School of Medicine   (Dominican Republic)

^k Centro de Desarrollo de Proyectos Avanzados Cordoba   (Argentina)

^l Paraná and Concordia National Hospitals   (Argentina)

^m Pilar National Hospital   (Argentina)

ⁿ Center for Investigation of Infectious Diseases   (Mexico)

^o Children's Hospital   (Uruguay)

^p HARVARD PILGRIM HEALTH CARE   (United States)

more..

Author keywords

Americas; Drug costs; Immunization programs; Pneumococcal vaccines; Streptococcus pneumoniae

Indexed keywords

PNEUMOCOCCUS VACCINE;

BACTERIUM; DISEASE CONTROL; HEALTH MONITORING; IMMUNIZATION; PNEUMONIA; VACCINATION;

ANTIBIOTIC RESISTANCE; ARGENTINA; BACTERIAL MENINGITIS; COLOMBIA; DOMINICAN REPUBLIC; FINANCIAL MANAGEMENT; GUATEMALA; HEALTH ECONOMICS; HEALTH SURVEY; HUMAN; MEXICO; PNEUMONIA; REVIEW; SEROTYPE; SOUTH AND CENTRAL AMERICA; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; UNITED STATES; URUGUAY; VACCINATION; WORLD HEALTH ORGANIZATION;

NORTH AMERICA; SOUTH AMERICA;

BACTERIA (MICROORGANISMS); RICE STRIPE VIRUS; STREPTOCOCCUS PNEUMONIAE;

EID: 33747448288     PISSN: 10204989     EISSN: 16805348     Source Type: Journal    
DOI: 10.1590/S1020-49892006000500007     Document Type: Review

References (9)

1. Pan American Health Organization. A culture of prevention: a model for control of vaccine-preventable diseases. XVI Meeting of the Technical Advisory Group on Vaccine-preventable Diseases. Mexico City - November 3-5, 2004. Final report. Washington, D.C.: PAHO; 2004.
2. World Health Organization. Pneumococcal vaccines. WHO position paper. Wkly Epidemiol Rec. 1999;74(23):177-83.
3. Plotkin SA, Orenstein W, eds. Vaccines. Third edition. Philadelphia: W.B. Saunders Co.; 1999.
4. Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003;348(18):1737-46.
5. Di Fabio JL, Castañeda E, Agudelo CI, de la Hoz F, Hortal M, Camou T, et al. Evolution of Streptococcus pneumoniae serotypes and penicillin susceptibility in Latin America, Sireva-Vigía Group, 1993 to 1999. Pediatr Infect Dis J. 2001;20(10):959-67.
6. Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J. 2000,19(3):187-95.
7. World Health Organization. Programme for Control of Acute Respiratory Infections. Interim programme report. Geneva: WHO; 1991. (Document WHO/ARI/91.19).
8. Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, Pierce N, et al. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med. 2003;349(14):1341-8.
9. World Health Organization, Department of Vaccines and Biologicals. Standardization of interpretation of chest radiographs for the diagnosis of pneumonia in children. Geneva: WHO; 2001. (Document WHO/V&B/01.35).